U.S., Feb. 15 -- ClinicalTrials.gov registry received information related to the study (NCT06827132) titled 'Observational Study Evaluate Pathology Practice Use Artificial Intelligence in Patient Suspected Lung and Breast Cancer' on Jan. 28.
Brief Summary: A multinational observational study to evaluate the current pathology practices and the utilization of computational pathology plus artificial intelligence algorithms in patients with suspected lung and breast cancer.
Study Start Date: March 15
Study Type: OBSERVATIONAL
Condition:
Lung Cancer
Breast Cancer
Recruitment Status: NOT_YET_RECRUITING
Sponsor: AstraZeneca
Published by HT Digital Content Services with permission from Health Daily Digest....